Intravascular Hemolysis After Transcatheter Aortic Valve Implantation in patients with Severe Aortic Stenosis: Observational, multicenter, prospective study
Not Applicable
Recruiting
- Conditions
- Severe Aortic Stenosis
- Registration Number
- JPRN-UMIN000046891
- Lead Sponsor
- The department of Cardiovascular Medicine at Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Any patients who are judged inappropriate by research director or co-investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms contribute to intravascular hemolysis after TAVI in severe aortic stenosis patients?
How does transcatheter aortic valve implantation compare to surgical aortic valve replacement in managing severe aortic stenosis complications?
What biomarkers are associated with increased risk of hemolysis following TAVI procedures in elderly patients with calcific aortic stenosis?
What are the most effective management strategies for intravascular hemolysis as a complication of TAVI in high-risk aortic stenosis populations?
Are there specific patient subtypes with severe aortic stenosis who experience higher rates of hemolytic anemia after transcatheter valve implantation?